SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061995
Filing Date
2023-11-09
Accepted
2023-11-09 16:04:51
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glue-20230930.htm   iXBRL 10-Q 2210523
2 EX-10.2 glue-ex10_2.htm EX-10.2 785622
3 EX-31.1 glue-ex31_1.htm EX-31.1 19544
4 EX-32.1 glue-ex32_1.htm EX-32.1 11564
  Complete submission text file 0000950170-23-061995.txt   8999706

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glue-20230930_def.xml EX-101.DEF 167203
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glue-20230930_lab.xml EX-101.LAB 437230
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glue-20230930_cal.xml EX-101.CAL 42857
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glue-20230930_pre.xml EX-101.PRE 337700
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glue-20230930.xsd EX-101.SCH 52516
70 EXTRACTED XBRL INSTANCE DOCUMENT glue-20230930_htm.xml XML 1466337
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40522 | Film No.: 231392236
SIC: 2836 Biological Products, (No Diagnostic Substances)